EXACT SCIENCES CORP Quarterly Marketable Securities, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Exact Sciences Corp quarterly Marketable Securities, Current history and growth rate from Q4 2010 to Q2 2024.
  • Exact Sciences Corp Marketable Securities, Current for the quarter ending June 30, 2024 was $417M, a 143% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $417M +$245M +143% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $305M +$27.3M +9.85% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $172M -$217M -55.8% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $140M -$294M -67.8% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $171M -$343M -66.7% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $277M -$350M -55.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $390M -$325M -45.5% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $434M -$511M -54.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $515M -$429M -45.5% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $627M +$353M +129% Mar 31, 2022 10-Q 2022-04-26
Q4 2021 $715M +$366M +105% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $945M +$468M +98.3% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $944M +$425M +82% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $274M -$256M -48.3% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $349M +$202M +138% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $476M +$350M +277% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 $519M -$516M -49.9% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $530M -$467M -46.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $146M -$817M -84.8% Dec 31, 2019 10-K 2021-02-16
Q3 2019 $126M -$897M -87.7% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $1.03B +$37.9M +3.8% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $998M +$104M +11.6% Mar 31, 2019 10-Q 2019-04-30
Q4 2018 $964M +$617M +178% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $1.02B +$612M +149% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 $997M +$693M +228% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $893M +$658M +279% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 $347M +$85M +32.4% Dec 31, 2017 10-K 2019-02-21
Q3 2017 $412M +$137M +50% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 $304M +$129M +73.6% Jun 30, 2017 10-Q 2017-07-25
Q1 2017 $235M +$25M +11.9% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $262M -$3.57M -1.34% Dec 31, 2016 10-K 2018-02-22
Q3 2016 $274M -$37.6M -12.1% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $175M -$1.99M -1.12% Jun 30, 2016 10-Q 2016-07-26
Q1 2016 $210M +$5.97M +2.92% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $266M +$41.1M +18.3% Dec 31, 2015 10-K 2017-02-21
Q3 2015 $312M +$129M +70.2% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $177M -$37M -17.3% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 $204M +$106M +108% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $225M +$104M +86.6% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $183M +$45.2M +32.7% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $214M +$77.9M +57.2% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $98.2M +$10.8M +12.3% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $120M +$25.6M +27% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $138M +$32.2M +30.4% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 $136M +$71.4M +110% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 $87.4M +$16.2M +22.7% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $94.8M +$37.2M +64.6% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $106M +$35.5M +50.4% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $64.8M +$19.6M +43.4% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 $71.2M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $57.6M +$40.9M +246% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $70.4M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $45.2M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $16.7M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.